Advertisement

Topics

Evoke’s experience with Thermo wins Patheon nasal metoclopramide contract

06:53 EST 13 Nov 2017 | in-PharmaTechnologis

Evoke Pharma has selected Patheon to commercially manufacture its nasal delivery formulation of metoclopramide Gimoti ahead of a planned US FDA submission next year.

Original Article: Evoke’s experience with Thermo wins Patheon nasal metoclopramide contract

NEXT ARTICLE

More From BioPortfolio on "Evoke’s experience with Thermo wins Patheon nasal metoclopramide contract"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...